Chemical Compound

N-Formyl-L-leucine (1S)-1-[(2R,3S)-3-Carboxy-2-hydroxynonyl]dodecyl Ester; (2S,3R,5S)-5-[(N-Formyl-L-leucyl)oxy]-2-hexyl-3-hydroxyhexadecanoic Acid

CAS Registry Number 130793-28-1
N-Formyl-L-leucine (1S)-1-[(2R,3S)-3-Carboxy-2-hydroxynonyl]dodecyl Ester; (2S,3R,5S)-5-[(N-Formyl-L-leucyl)oxy]-2-hexyl-3-hydroxyhexadecanoic Acid 结构式
Primary record

N-Formyl-L-leucine (1S)-1-[(2R,3S)-3-Carboxy-2-hydroxynonyl]dodecyl Ester; (2S,3R,5S)-5-[(N-Formyl-L-leucyl)oxy]-2-hexyl-3-hydroxyhexadecanoic Acid

库存
9,239 克
纯度
99.4 %
CAS
130793-28-1

化合物标识与属性

CAS
130793-28-1
PubChem CID
59434860
SMILES
CCCCCCCCCCC[C@@H](C[C@H]([C@H](CCCCCC)C(=O)O)O)OC(=O)[C@H](CC(C)C)NC=O
Canonical SMILES
CCCCCCCCCCC[C@@H](C[C@@H](O)[C@H](CCCCCC)C(=O)O)OC(=O)[C@H](CC(C)C)NC=O

名称与同义词

  • orlistat open ring epimer
  • Orlistat Impurity
  • (Orlistat Impurity)
  • F0N5S1WW2U
  • (Orlistat Impurity)"
  • 130793-28-1
  • UNII-F0N5S1WW2U
  • RefChem:856917
  • SCHEMBL13210079
  • C29H55NO6
  • Orlistat open ring epimer (M1)
  • Orlistat open ring epimer [USP IMPURITY]
  • DTXSID801147205
  • MFCD12407132
  • ZINC72399855
  • IF23585
  • Orlistat Open Ring (2S,3R,5S)-Isomer
  • DB-278470
  • FT-0668832
  • (2S,3R,5S)-5-[(N-Formyl-L-leucyl)oxy]-2-hexyl-3-hydroxyhexadecanoic acid
  • (2S,3R,5S)-5-[(N-Formyl-L-leucyl)oxy]-2-hexyl-3-hydroxyhexadecanoic Acid (Orlistat Impurity)
  • L-Leucine, N-formyl-, (1S)-1-[(2R,3S)-3-carboxy-2-hydroxynonyl]dodecyl ester
  • ORLISTAT OPEN RING EPIMER (USP IMPURITY)
  • L-Leucine, N-formyl-, (1S)-1-((2R,3S)-3-carboxy-2-hydroxynonyl)dodecyl ester
  • N-Formyl-L-leucine (1S)-1-((2R,3S)-3-carboxy-2-hydroxynonyl)dodecyl ester
  • (2S,3R,5S)-5-((S)-2-Formylamino-4-methyl-pentanoyloxy)-2-hexyl-3-hydroxy-hexadecanoic acid
  • Q27277485
  • N-Formyl-L-leucine (1S)-1-[(2R,3S)-3-carboxy-2-hydroxynonyl]dodecyl ester
  • (2S,3R,5S)-5-[(2S)-2-formamido-4-methylpentanoyl]oxy-2-hexyl-3-hydroxyhexadecanoic acid
  • Orlistat USP Related Compound (Orlistat open ring epimer)
  • [2R-[1(S*),2R*,3S*]]-N-Formyl-L-Leucine 1-[3-Carboxy-2-hydroxynonyl]dodecyl Ester
  • (2S, 3R, 5S)-5-[(N-FORMYL-L-LEUCYL)OXY]-2-HEXYL-3-HYDROXYHEXADECANOIC ACID
  • (2S,3R,5S)-5-[(2S)-2-formamido-4-methyl-pentanoyl]oxy-2-hexyl-3-hydroxy-hexadecanoic acid
  • (2S,3R,5S)-5-[(N-FORMYLLEUCYL)OXY]-2-HEXYL-3-HYDROXYHEXADECANOIC ACID
  • (2S,3R,5S)-5-[(N-Formyl-L-leucyl)oxy]-2-hexyl-3-hydroxyhexadecanoic acid(orlistat impurity)
  • (2S,3S,5S)-5-[[(S)-2-(Formylamino)-4-methylpentanoyl]oxy]-2-hexyl-3-hydroxyhexadecanoic Acid
  • N-Formyl-L-leucine (1S)-1-[(2R,3S)-3-Carboxy-2-hydroxynonyl]dodecyl Ester; (2S,3R,5S)-5-[(N-Formyl-L-leucyl)oxy]-2-hexyl-3-hydroxyhexadecanoic Acid
  • Orlistat Related Compound ((2S,3R,5S)-5-[(N-Formyl-L-leucyl)oxy]-2-hexyl-3-hydroxyhexadecanoic acid)